The Union government has waived
import duty and GST of Rs 6 crore on medicines for a five- month-old girl suffering from a rare medical condition, BJP leader Devendra Fadnavis said on Tuesday.
Teera Kamat, admitted in a suburban hospital, suffers from Spinal Muscular Atrophy in which a complete breakdown of nerve cells results in zero control over muscle movement.
Her parents, Priyanka and Mihir Kamat, had written on social media about their child's fight with a debilitating ailment, leading to fund raising as well as appeals to the Union government to waive import duty and GST on medicines.
Among the medicines is Zolgensma which targets the root cause of SMA and which has to be imported.
In their social media appeals, Teera's parents had said that 23 per cent import duty and 12 per cent GST added Rs 6 crore to the cost of Rs 16 crore that the treatment entails.
Fadnavis, on February 1, had written to the Centre requesting a waiver of import duty and GST.
"I would like to thank you from bottom of my heart for extremely humanitarian and sensitive approach and quick action for exempting customs duty for importing life saving drug Zolgensma for five month old Teera Kamat from Mumbai," Fadnavis said in a letter to the Prime Minister's Office on Tuesday.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)